Vestibular Function and Vestibular Rehabilitation in SSHL With Vertigo
1 other identifier
interventional
80
1 country
1
Brief Summary
To evaluate the vestibular function and vestibular rehabilitation in sudden sensorneural hearing loss(SSHL) with vertigo
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 16, 2018
CompletedFirst Posted
Study publicly available on registry
February 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedFebruary 13, 2018
February 1, 2018
1.5 years
January 16, 2018
February 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 1(before treatment)
Vestibular function status in SSHL with vertigo at stage 1(before treatment)
before treatment
Secondary Outcomes (2)
Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 weeks after treatment)
2 weeks after treatment
Assessment of vestibular function status by vestibular function tests in SSHL with vertigo at stage 2(2 months after treatment)
2 months after treatment
Study Arms (2)
non-training group
ACTIVE COMPARATORtraining group
EXPERIMENTALInterventions
Vestibular Rehabilitation Exercises
Eligibility Criteria
You may qualify if:
- A rapid onset sensorineural hearing loss of more than 30 dB for at least three contiguous audiometric frequencies within a period of 3 days, according to standard AAO - HNS;
- Within 10 days from onset;
- Without other virus infectious disease within three months.
You may not qualify if:
- BPPV; Meniere's disease and vestibular migraine.
- With certain Known etiology, including acoustic neuroma, heart cerebrovascular accident, injury, Hunt syndrome, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, 200031, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2018
First Posted
February 13, 2018
Study Start
December 1, 2017
Primary Completion
May 30, 2019
Study Completion
December 30, 2019
Last Updated
February 13, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share